NAGE (Niagen Bioscience, Inc.) is set to announce its Q2'26 results on August 04, after the market closes. The earnings are expected to be disclosed at 4:02 PM ET (8:02 PM UTC).
For Q2'26, revenue estimate is 30.53 million USD with EPS (earnings per share) anticipated at 0.01 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported31.12 M33.99 M33.84 M31.47 M— | Revenue Estimate28.31 M31.20 M31.70 M31.03 M30.53 M | Revenue Surprise+9.92%+8.92%+6.74%+1.43% | EPS Reported0.040.050.050.07 | EPS Estimate0.010.020.020.070.01 | EPS Surprise+344.44%+185.71%+127.27%+2.94% |